Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

25 Jan 2019 07:00

RNS Number : 0641O
Barr(A.G.) PLC
25 January 2019
 

 

 

IMMEDIATE RELEASE 25 January 2019

A.G. BARR p.l.c.

("A.G. BARR")

Trading Update

A.G. BARR p.l.c., which produces and markets some of the UK's leading drinks brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a pre-close trading update in respect of the financial year (52 weeks) ending 26 January 2019.

 

We are pleased to report a continued positive trading performance across the period with revenue expected to be c.£277m, up c.5% on the prior year (2017/18 : £264.1m1).

 

Strong trading execution across our core brands and the continued success of our key innovation have led to further market share volume gains in a UK soft drinks market which saw volume up 3.0% while value increased by 8.0% (Source : IRI Marketplace 48 weeks to 30 December 2018).

 

The impact of the Soft Drinks Industry Levy has been evident across the UK soft drinks market with value growth significantly outstripping volume in the period. Having taken the opportunity to drive our volume growth during this period, we expect to return to a more value-led trading strategy in 2019.

 

Throughout the year we have remained committed to investing across our brands, assets and people which, while supporting our growth, has had a moderate impact on operating margin.

 

Our tight control on costs has been maintained and our balance sheet remains robust. The £30m share repurchase programme has continued and we now expect it to complete during the course of 2019, slightly later than previously indicated.

 

For the financial year ending 26 January 2019, we remain confident of delivering profit ahead of the prior year and in line with the Board's expectations.

 

Outlook

Looking ahead, the current political and economic uncertainty in the UK looks set to continue. For the soft drinks industry, further regulatory intervention is on the horizon and consumer dynamics continue to evolve. Our strong and flexible business model, our portfolio of differentiated and growing brands and our well-invested and efficient asset base give us confidence for continued profitable growth as we enter a new financial year.

 

A.G. BARR intends to announce its full year financial results on 26 March 2019.

 

For further information, please contact:

 

A.G. BARR

Tel: 0330 390 3900

Roger White, Chief Executive

Stuart Lorimer, Finance Director

 

Instinctif Partners

Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

 

 

1 All numbers reflect the adoption of IFRS 15 "Revenue from Contracts with Customers". Certain costs payable to customers, previously presented as expenses, are now shown as a deduction to revenue. There has been a £13.6m restatement to the prior year to enable an accurate comparison of performance.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAXFLADDNEFF
Date   Source Headline
2nd Aug 20177:00 amRNSTrading Update
28th Jul 20175:00 pmRNSClose period repurchase programme
26th Jul 20177:00 amRNSTransaction in Own Shares
25th Jul 20171:45 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSTransaction in Own Shares
24th Jul 20171:37 pmRNSDirector/PDMR Shareholding
17th Jul 20178:09 amRNSTransaction in Own Shares
14th Jul 20177:43 amRNSTransaction in Own Shares
13th Jul 201710:07 amRNSNotice of Trading Update
10th Jul 20172:21 pmRNSDirector/PDMR Shareholding
28th Jun 20177:13 amRNSTransaction in Own Shares
27th Jun 201712:14 pmRNSTransaction in Own Shares
14th Jun 20173:25 pmRNSDirector/PDMR Shareholding
14th Jun 20177:00 amRNSTransaction in Own Shares
13th Jun 20177:14 amRNSTransaction in Own Shares
12th Jun 20171:33 pmRNSDirector/PDMR Shareholding
12th Jun 20171:32 pmRNSDirector/PDMR Shareholding
12th Jun 20171:30 pmRNSDirector/PDMR Shareholding
12th Jun 20171:28 pmRNSDirector/PDMR Shareholding
8th Jun 20172:02 pmRNSDirector/PDMR Shareholding
6th Jun 20174:04 pmRNSDirector/PDMR Shareholding
31st May 201712:38 pmRNSAGM Statement
18th May 20177:00 amRNSTransaction in Own Shares
9th May 20171:20 pmRNSDirector/PDMR Shareholding
3rd May 20179:43 amRNSDirector/PDMR Shareholding
27th Apr 20174:08 pmRNSAnnual Report and Accounts and Notice of AGM
26th Apr 201712:17 pmRNSDirector/PDMR Shareholding
10th Apr 201712:12 pmRNSDirector/PDMR Shareholding
3rd Apr 20173:47 pmRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFinal Results
8th Mar 20172:49 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSFurther reduction of sugar across portfolio
8th Feb 20171:34 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTrading Update
12th Jan 20177:00 amRNSNotice of Trading Update
10th Jan 20172:10 pmRNSDirector/PDMR Shareholding
9th Jan 20174:35 pmRNSPrice Monitoring Extension
9th Jan 20172:56 pmRNSDirector Declaration
13th Dec 20167:00 amRNSAnalyst Site Visit
8th Dec 201612:42 pmRNSDirector/PDMR Shareholding
14th Nov 201611:23 amRNSHolding(s) in Company
10th Nov 20162:59 pmRNSHolding(s) in Company
8th Nov 201612:42 pmRNSDirector/PDMR Shareholding
25th Oct 201611:33 amRNSDirector/PDMR Shareholding
25th Oct 201611:20 amRNSDirector/PDMR Shareholding
25th Oct 201611:19 amRNSDirector/PDMR Shareholding
25th Oct 201611:13 amRNSDirector/PDMR Shareholding
10th Oct 20161:27 pmRNSDirector/PDMR Shareholding
28th Sep 20162:13 pmRNSCorrection: Interim Results
27th Sep 20167:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.